Array BioPharma Competitors and Similar CompaniesClear all
Amicus Therapeutics's competitors and similar companies include NIOX.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | |
Founding Date | Founding Date 2002 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US |
Employees | Employees 58415% increase | Employees 91 |
Valuation ($) | Valuation ($) 3.4 b | Valuation ($) 340.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $634.2m (FY, 2025) | Revenue (est.) £48.7m (FY, 2025) |
Cost of goods | Cost of goods $72.9m (FY, 2025) | Cost of goods £11.1m (FY, 2025) |
Gross profit | Gross profit $561.3m (FY, 2025) | Gross profit £38.2m (FY, 2025) |
Net income | Net income ($27.1m) (FY, 2025) | Net income £7m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 88m | Total funding raised $ 122.8m |
For sources of this data, please see the company profile
View Company Profiles
NIOX
HQ
Morrisville, US
Employees
91
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View company